Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer
- PMID: 18562222
- DOI: 10.1016/j.urolonc.2008.02.015
Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer
Abstract
Objectives: Urinary bladder cancer is the fifth most common form of cancer in humans in the United States. Urinary bladder cancer also occurs in pet dogs, and naturally-occurring bladder cancer in pet dogs very closely resembles invasive bladder cancer (intermediate to high grade invasive transitional cell carcinoma, InvTCC) in humans. Pet dogs with InvTCC offer a highly relevant resource for preclinical studies in bladder cancer. For translational research in which findings are moved from in vitro experiments through in vivo studies in dogs to human trials, access to human and canine bladder cancer cell lines is important. Cell lines derived from canine InvTCC have been lacking. Here we describe eight such cell lines.
Materials and methods: Eight cell lines were established from canine InvTCC. Cells were characterized using immunocytochemistry, evaluated for anchorage independent growth in soft agar, and assessed for tumorigenicity in athymic mice. Western blotting was used to identify expression of proteins of interest in human InvTCC.
Results: The cell lines were confirmed to be of epithelial origin by their expression of cytokeratin and E-cadherin. Seven cell lines were found to be tumorigenic in athymic mice, and 4 of these cell lines grew in an anchorage independent manner. The cell lines expressed several proteins of interest associated with bladder cancer prognosis and progression in humans, including p53, cox-2, and pRb protein.
Conclusions: These established cell lines can be used for comparative bladder cancer research and to evaluate new therapy approaches in vitro prior to in vivo testing.
Similar articles
-
Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo.Urology. 2008 Jan;71(1):156-60. doi: 10.1016/j.urology.2007.09.061. Urology. 2008. PMID: 18242386
-
Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies.J Pathol. 2008 Jun;215(2):184-94. doi: 10.1002/path.2346. J Pathol. 2008. PMID: 18393367
-
Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder.J Urol. 2003 Sep;170(3):985-9. doi: 10.1097/01.ju.0000080401.85145.ee. J Urol. 2003. PMID: 12913755
-
[Animal experiment aspects of bladder cancer].Urologe A. 1991 May;30(3):172-9. Urologe A. 1991. PMID: 1871936 Review. German.
-
Molecular alterations associated with bladder cancer initiation and progression.Scand J Urol Nephrol Suppl. 2008 Sep;(218):154-65. doi: 10.1080/03008880802291915. Scand J Urol Nephrol Suppl. 2008. PMID: 18815930 Review.
Cited by
-
Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans.Front Oncol. 2020 Jan 21;9:1493. doi: 10.3389/fonc.2019.01493. eCollection 2019. Front Oncol. 2020. PMID: 32039002 Free PMC article. Review.
-
RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures.Cancer Cell Int. 2022 Feb 2;22(1):54. doi: 10.1186/s12935-021-02422-9. Cancer Cell Int. 2022. PMID: 35109825 Free PMC article.
-
Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand.Mol Cancer. 2011 Jan 27;10(1):9. doi: 10.1186/1476-4598-10-9. Mol Cancer. 2011. PMID: 21272294 Free PMC article.
-
Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans.Cancer Res Commun. 2023 May 15;3(5):860-873. doi: 10.1158/2767-9764.CRC-22-0468. eCollection 2023 May. Cancer Res Commun. 2023. PMID: 37377896 Free PMC article.
-
Preclinical Models for Bladder Cancer Research.Hematol Oncol Clin North Am. 2021 Jun;35(3):613-632. doi: 10.1016/j.hoc.2021.02.007. Epub 2021 Apr 16. Hematol Oncol Clin North Am. 2021. PMID: 33958154 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous